Skip to content
DraconiticResearch
Search Sources API
186,125 studies31 sourcesUpdated 9 min ago
PreprintCC BYChemRxiv

Computational shielding of dengue viral prefusion with permeable cyclic-minipeptides

Abstract

Permeable cyclic-minipeptide-conformer candidates have been computationally cogenerated to shield the protected prefusionloops (FL) of dengue flavivirus (DENV). The objective was to prevent the pH-dependent dissociation events that trigger flavivirus fusion/ infectivity by exposing the FL highlyconserved sequences to homotrimer fusioncompetent conformations. For that, hundreds of BoltzGen candidates were co-generated targeting a prefusion minimized DENV envelope AB heterodimer (minEAB) model including both EA-protective and EB-FL sequences. The advantages of the newly cogenerated top-affinity nanoMolar candidates include possible bypassing of antibody-related enhancements, low antigenicity, easy chemical synthesis, and strong environmentalphysiological stability. Additionally, top-affinity parents were mutated to derive membranepermeable candidates conserving cyclization, minEAB targets and high-affinities. A few membrane-permeable candidates may serve for in vitro and animal-model experimentallyguided validations of inhibition of DENV fusion and infection.

Related

  1. Computational shielding of chikungunya viral prefusion with permeable cyclic-minipeptides
    Julio Coll
    ChemRxivPreprintCC BYFull textMolecular biology & gene regulationChemRxiv
  2. Computational Insights into Mechanostability and Dissociation Dynamics of the Dengue Virus Envelope Protein Ectodomain Dimer Across pH and Temperature Gradients
    Georcki Ropón-Palacios, Luís G. F. Crespi, Jakub Rydzewski +2
    arXivPreprintCC BY 4.0Full textBiophysicsPhysical chemistryarXiv
  3. Generation of membrane-permeable cyclic peptides inhibiting protein–protein interaction
    Xinjian Ji, Lluc Farrera Soler, Jiajun Li +9
    Nature Chemical BiologyPeer-reviewedCC BY7 citedMolecular biology & gene regulationOpenAlex
  4. A permeable G310 constriction limits K+ flux in the activated KCNQ2 pore and is disrupted by the encephalopathy variant G310S
    S. Qoshimboyev, P. Marimuthu, M. Makhkamov +1
    bioRxivPreprintCC BYFull textBiophysicsbioRxiv
  5. Strain-Dependent Cross-Neutralization of Closely Related Asian-Lineage Zika Viruses by Dengue-Immune Sera
    Jia-Yi Tan, Nurhafiza Zainal, Sazaly AbuBakar +1
    BiomoleculesPeer-reviewedCC BYFull textGeneral biochemistryEurope PMC
BibTeX
@misc{coll2026computational,
  title = {{Computational shielding of dengue viral prefusion with permeable cyclic-minipeptides}},
  author = {Julio Coll},
  howpublished = {ChemRxiv},
  year = {2026},
  month = sep,
  doi = {10.26434/chemrxiv.15008305/v1},
  url = {https://chemrxiv.org/doi/full/10.26434/chemrxiv.15008305/v1},
  note = {CC BY},
}
RIS
TY  - UNPB
TI  - Computational shielding of dengue viral prefusion with permeable cyclic-minipeptides
AU  - Julio Coll
PY  - 2026
DA  - 2026/09/04
PB  - ChemRxiv
DO  - 10.26434/chemrxiv.15008305/v1
UR  - https://chemrxiv.org/doi/full/10.26434/chemrxiv.15008305/v1
AB  - Permeable cyclic-minipeptide-conformer candidates have been computationally cogenerated to shield the protected prefusionloops (FL) of dengue flavivirus (DENV). The objective was to prevent the pH-dependent dissociation events that trigger flavivirus fusion/ infectivity by exposing the FL highlyconserved sequences to homotrimer fusioncompetent conformations. For that, hundreds of BoltzGen candidates were co-generated targeting a prefusion minimized DENV envelope AB heterodimer (minEAB) model including both EA-protective and EB-FL sequences. The advantages of the newly cogenerated top-affinity nanoMolar candidates include possible bypassing of antibody-related enhancements, low antigenicity, easy chemical synthesis, and strong environmentalphysiological stability. Additionally, top-affinity parents were mutated to derive membranepermeable candidates conserving cyclization, minEAB targets and high-affinities. A few membrane-permeable candidates may serve for in vitro and animal-model experimentallyguided validations of inhibition of DENV fusion and infection.
ER  -